Comparative Pharmacology
Head-to-head clinical analysis: CALCIUM GLUCEPTATE versus HEMICLOR.
Peer-Reviewed Evidence
Head-to-head clinical analysis: CALCIUM GLUCEPTATE versus HEMICLOR.
CALCIUM GLUCEPTATE vs HEMICLOR
Comparing the clinical profiles, pharmacokinetic behaviors, and safety indices of these two therapeutic agents.
Calcium gluceptate is a calcium salt that dissociates to provide calcium ions, which are essential for various physiological processes including nerve conduction, muscle contraction, blood coagulation, and cardiac function. It acts as a calcium replenisher.
Hemichlor (HEMICLOR) is a brand name for a combination product containing chlorpheniramine and pseudoephedrine. Chlorpheniramine is a first-generation antihistamine that antagonizes histamine at H1 receptor sites, reducing allergic symptoms. Pseudoephedrine is a sympathomimetic amine that directly stimulates alpha-adrenergic receptors, causing vasoconstriction and decongestion.
IV: 2-4 mg/kg elemental calcium (5-10 mL of 0.45 mEq/mL solution) administered slowly over 10-20 minutes. May repeat if needed. Maximum dose: 20 mL per infusion.
50-100 mg intravenously every 6 hours or 100 mg orally every 12 hours.
None Documented
None Documented
Terminal elimination half-life: 2-4 hours (normal renal function); prolonged to 12-24 hours in renal impairment.
Terminal elimination half-life 18–24 hours in normal renal function; prolonged to 36–48 hours in moderate renal impairment (CrCl 30–50 mL/min); adjust dosing interval in renal disease.
Renal: >90% excreted unchanged in urine. Biliary/fecal: <5%.
Primarily renal (85–90% as unchanged drug via glomerular filtration and tubular secretion); biliary/fecal < 5%.
Category C
Category C
Electrolyte Supplement
Electrolyte Supplement